Human/Primate GDF-15 Antibody Summary
Ala197-Ile308
Accession # Q99988
Applications
Human/Primate GDF-15 Sandwich Immunoassay
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: GDF-15
Growth Differentiation Factor 15 (GDF-15), also called Macrophage inhibitory cytokine-1 (MIC-1), placental transforming growth factor-beta, prostate-derived factor, and placental bone morphogenetic protein, is a divergent member of the transforming growth factor beta (TGF-beta ) superfamily. GDF-15 is highly expressed in placenta and is expressed at lower levels in kidney, pancreas, prostate and colon. It is also widely expressed in brain. Similarly to other TGF-beta family proteins, GDF-15 is synthesized as a large precursor protein that is cleaved at the dibasic cleavage site (RXXR) to release the carboxy-terminal domain. The carboxy-terminal domain of GDF-15 contains the characteristic seven conserved cysteine residues necessary for the formation of the cysteine knot and the single interchain disulfide bond. Furthermore, the carboxy-terminal domain contains two additional cysteine residues that form a fourth intrachain disulfide bond. Biologically active GDF-15 is a disulfide-linked homodimer of the carboxy-terminal 112 amino acid residues. Mature human GDF-15 shares 66.1% and 68.7% amino acid sequence similarity with rat and mouse GDF-15, respectively, which are remarkably low homologies between species in TGF-beta superfamily. GDF-15 has been shown to have various functions, including inhibition of production of tumor necrosis factor alpha (TNF-alpha ) from lipopolysaccharide-stimulated macrophages, induction of cartilage formation, early-stage endochonadal bone formation, and promotion of neuronal survival.
- Bootcov, M.R. et al. (1997) Proc. Natl. Acad. Sci. USA 94:11514.
- Böttner, M. et al. (1999) Gene 237:105.
- Fairlie, W.D. et al. (1998) J. Leukoc. Biol 65:2.
- Fairlie, W.D. et al. (2001) J B.C 20:16911.
- Bauskin, A.R. et al. (2000) EMBO J. 19:2212.
- Strelau, J. et al. (2000) J. Neurosci. 20:8597.
- Schober, A. et al. (2001) J. Comp. Neurol. 439:32.
Product Datasheets
Citations for Human/Primate GDF-15 Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
16
Citations: Showing 1 - 10
Filter your results:
Filter by:
-
GDF15 promotes osteosarcoma cell migration and invasion by regulating the TGF‑ beta signaling pathway
Authors: Guangfu Chen, Min Wang, Xiang Liu
Molecular Medicine Reports
-
Growth differentiation factor 15 is a promising diagnostic and prognostic biomarker in colorectal cancer
Authors: Chen Li, Xiaobing Wang, Ignacio Casal, Jingyu Wang, Peiwei Li, Wei Zhang et al.
Journal of Cellular and Molecular Medicine
-
Growth differentiation factor 15 induces cisplatin resistance through upregulation of xCT expression and glutathione synthesis in gastric cancer
Authors: Wang, SF;Chang, YL;Fang, WL;Li, AF;Chen, CF;Yeh, TS;Hung, GY;Huang, KH;Lee, HC;
Cancer science
Species: Human
Sample Types: Cell Lysates, Whole Cells
Applications: Western Blot, Neutralization -
Increased expression and accumulation of GDF15 in IPF extracellular matrix contribute to fibrosis
Authors: A Radwanska, CT Cottage, A Piras, C Overed-Say, C Sihlbom, R Budida, C Wrench, J Connor, S Monkley, P Hazon, H Schluter, MJ Thomas, CM Hogaboam, LA Murray
JCI Insight, 2022-08-22;7(16):.
Species: Mouse
Sample Types: In Vivo
Applications: In Vivo -
Circulating levels of GDF15 in patients with myalgic encephalomyelitis/chronic fatigue syndrome
Authors: A Melvin, E Lacerda, HM Dockrell, S O'Rahilly, L Nacul
J Transl Med, 2019-12-04;17(1):409.
Species: Human
Sample Types: Serum
Applications: ELISA Capture -
TGF-? contamination of purified recombinant GDF15
Authors: OE Olsen, A Skjærvik, BF Størdal, A Sundan, T Holien
PLoS ONE, 2017-11-21;12(11):e0187349.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization -
GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson's Disease and Lewy Body Dementia.
Authors: Walter Maetzler, Willy Deleersni, Valérie Hanssens, Alice Bernard, Kathrin Brockmann, Justus Marquetan, Isabel Wurster, Tim W Rattay, Lorenzo Roncoroni, Eva Schaeffer, Stefanie Lerche, Anja Apel, Christian Deuschle, Daniela Berg
PLoS ONE, 2016-03-03;0(0):1932-6203.
Species: Human
Sample Types: Beads
Applications: Luminex Development -
Macrophage inhibitory cytokine 1 biomarker serum immunoassay in combination with PSA is a more specific diagnostic tool for detection of prostate cancer.
Authors: Li, Ji, Veltri, Robert W, Yuan, Zhen, Christudass, Christhu, Mandecki, Wlodek
PLoS ONE, 2015-04-08;10(4):e0122249.
Species: Human
Sample Types: Serum
Applications: ELISA Development (Capture) -
Growth differentiating factor 15 enhances the tumor-initiating and self-renewal potential of multiple myeloma cells.
Authors: Tanno, Toshihik, Lim, Yiting, Wang, Qiuju, Chesi, Marta, Bergsagel, P Leif, Matthews, Geoff, Johnstone, Ricky W, Ghosh, Nilanjan, Borrello, Ivan, Huff, Carol An, Matsui, William
Blood, 2013-12-17;123(5):725-33.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization -
Growth differentiation factor-15 predicts mortality and morbidity after cardiac resynchronization therapy.
Authors: Foley PW, Stegemann B, Ng K, Ramachandran S, Proudler A, Frenneaux MP, Ng LL, Leyva F
Eur. Heart J., 2009-08-07;30(22):2749-57.
Species: Human
Sample Types: Plasma
Applications: ELISA Development -
Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
Authors: Khan SQ, Ng K, Dhillon O, Kelly D, Quinn P, Squire IB, Davies JE, Ng LL
Eur. Heart J., 2009-01-23;30(9):1057-65.
Species: Human
Sample Types: Plasma
Applications: ELISA Development -
Diet-induced macrophage inhibitory cytokine 1 promotes prostate cancer progression
Authors: Mingguo Huang, Shintaro Narita, Takamitsu Inoue, Norihiko Tsuchiya, Shigeru Satoh, Hiroshi Nanjo et al.
Endocrine-Related Cancer
-
Visfatin Mediates Malignant Behaviors through Adipose-Derived Stem Cells Intermediary in Breast Cancer
Authors: Jyun-Yuan Huang, Yen-Yun Wang, Steven Lo, Ling-Ming Tseng, Dar-Ren Chen, Yi-Chia Wu et al.
Cancers (Basel)
-
Hyperbaric Oxygen Exposure Attenuates Circulating Stress Biomarkers: A Pilot Interventional Study
Authors: Jae Seung Chang, Eunha Chang, Yoonsuk Lee, Yong Sung Cha, Seung-Kuy Cha, Won Gil Cho et al.
International Journal of Environmental Research and Public Health
-
The role of growth differentiation factor 15 in the pathogenesis of primary myelofibrosis.
Authors: Uchiyama T, Kawabata H, Miura Y et al.
Cancer Med
-
GDF15 promotes EMT and metastasis in colorectal cancer
Authors: Chen Li, Jingyu Wang, Jianlu Kong, Jinlong Tang, Yihua Wu, Enping Xu et al.
Oncotarget
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human/Primate GDF-15 Antibody
Average Rating: 4.6 (Based on 7 Reviews)
Have you used Human/Primate GDF-15 Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Filter by:
This antibody was used as capture in an ELISA with BAF940 as the detection. Human Serum and Plasma samples were measurable.
Together with cat# BAF940 this antibody was used in an immunoassay to measure GDF-15 in human serum samples.
Human uterine endothelial cells were cultured in Extravillous trophoblasts conditioned medium. Antibody was used to neutralize Extravillous trophoblast secreted GDF-15.
